The integration of genomic and precision medicine into health care offers enormous opportunities to improve human health, but there is significant risk that these emerging therapies will worsen inequities instead of alleviating them. The insights of genomic medicine are currently derived from data that fails to include enough members of underserved populations; as a consequence, genomic variant interpretation may, in some cases, be incorrect for members of racial and ethnic minorities in the US. Recruitment and retention of diverse and representative populations of research participants remain a challenge.
The goal of this conference was to investigate what role law and policy are playing in creating these inequities, and what legal and regulatory changes can be made to ensure that genomic and precision medicine don’t replicate or worsen existing health disparities. By assembling leading thinkers, clinicians, scientists, and activists at the intersection of law, policy, genomics, and disparities analysis, this event was the first to focus on the role of law and policy in advancing genomics and precision medicine to promote health equity.
This conference was held at:
The Cal Turner Family Center for Student Education
Meharry Medical College
1011 21st Ave. North
Nashville, TN 37208
Presented in collaboration with the Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center, and the Consortium on Law & Values in Health, Environment & the Life Sciences and Minnesota Precision Medicine Collaborative, University of Minnesota. It is part of the NIH-funded LawSeqSM project, which is dedicated to building a sound legal foundation for translating genomics into clinical application.
Articles resulting from this conference will be published in a special symposium of Ethnicity & Disease that will be guest edited by Marino A. Bruce (Vanderbilt University), Vence L. Bonham (National Human Genome Research Institute - NHGRI) and Susan M. Wolf (University of Minnesota).
Continuing Education Credit
Meharry Medical College is accredited by the Accreditation Council on Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
American Medical Association (AMA)
Meharry Medical College designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.
Following completion of this activity, learners should be better able to:
- Explain current research at the intersection of law, genomic medicine and health inequities;
- Describe policy and legal tools for minimizing health disparities in the translation of genomic medicine to clinical practice;
- Discuss and propose solutions to protect underserved, immigrant, and vulnerable populations while involving them in genomic research and translational medicine.
This interactive, comprehensive, informative, session will provide professional education to physicians, nurses, healthcare administrators, allied health professionals as well as attorneys, policy makers, faculty, researchers, students, and interested community members.
Continuing Education Credit Designation for Attorneys:
The Minnesota State Board of Continuing Legal Education has approved 5.5 Continuing Legal Education (CLE) credits for both the live conference and live webcast; Event Code is 262082.
The State of Tennessee has approved Continuing Legal Education (CLE) General 4.50 credits. In-person attendance: Event code is 229922. Live website participation: Event code 230035.